KemPharm, Inc. Gains 34.79%
Thu, Dec 26, 2019 at 05:30 PM
KemPharm, Inc. (KMPH:NASDAQ) rocketted at $0.37, representing a gain of 34.8%. The stock appeared on our News Catalysts scanner on Thu 26 Dec 19 at 12:29 PM in the 'AGREEMENT' category. From Wed 04 Dec 19, the stock recorded 21.43% Up Days and 13.33% Green Days
About KemPharm, Inc. (KMPH:NASDAQ)
KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that believe will be improved versions of widely prescribed, approved drugs.
Top 10 Gainers:
- China Rapid Finance Limited (XRF:NYSE), 113.11%
- Mereo BioPharma Group plc (MREO:NASDAQ), 97.25%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 54.1%
- Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 50%
- Phathom Pharmaceuticals, Inc. (PHAT:NASDAQ), 47.21%
- Verona Pharma plc (VRNA:NASDAQ), 44.93%
- Liquidia Technologies, Inc. (LQDA:NASDAQ), 43.47%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 43.23%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 37.49%
- KemPharm, Inc. (KMPH:NASDAQ), 34.79%